<?xml version="1.0" encoding="UTF-8"?>
<urlset
  xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
>
  <url>
    <loc>https://alphastocksinsight.com/articles/slb-slb-launches-ai-digital-marketplace-as-nvidia-partnership-takes-center-stage</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-18T23:35:53Z</news:publication_date>
      <news:title>SLB Launches AI Digital Marketplace as NVIDIA Partnership Takes Center Stage</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/hims-barclays-raises-hims-hers-hims-price-target-to-39-on-glp-1-momentum</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-18T23:34:32Z</news:publication_date>
      <news:title>Barclays Raises Hims &amp; Hers (HIMS) Price Target to $39 on GLP-1 Momentum</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/mrvl-marvell-mrvl-jumps-7-27-as-amazon-plans-to-sell-trainium-ai-chips-externally</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-18T23:33:55Z</news:publication_date>
      <news:title>Marvell (MRVL) Jumps 7.27% as Amazon Plans to Sell Trainium AI Chips Externally</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/kr-kroger-nyse-kr-q1-2026-eps-misses-estimates-as-price-cuts-and-transport-costs</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-18T23:33:01Z</news:publication_date>
      <news:title>Kroger (NYSE: KR) Q1 2026 EPS Misses Estimates as Price Cuts and Transport Costs Weigh</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/acn-accenture-nyse-acn-reports-fiscal-q3-2026-eps-of-3-80-beating-estimates-as</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-18T23:32:39Z</news:publication_date>
      <news:title>Accenture (NYSE: ACN) Reports Fiscal Q3 2026 EPS of $3.80, Beating Estimates as Corporate Spending Pulls Back</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/abcl-abcellera-jazz-pharmaceuticals-sign-848m-t-cell-antibody-collaboration-nasdaq</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-17T23:18:58Z</news:publication_date>
      <news:title>AbCellera, Jazz Pharmaceuticals Sign $848M T-Cell Antibody Collaboration (NASDAQ: ABCL)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/ntla-intellia-s-phase-3-crispr-therapy-cuts-hae-attacks-by-87-advancing-regulatory</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-17T23:18:38Z</news:publication_date>
      <news:title>Intellia&apos;s Phase 3 CRISPR Therapy Cuts HAE Attacks by 87%, Advancing Regulatory Path</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/goss-gossamer-bio-converts-181m-of-2027-notes-into-new-secured-debt-and-equity</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-17T23:18:02Z</news:publication_date>
      <news:title>Gossamer Bio Converts $181M of 2027 Notes Into New Secured Debt and Equity (NASDAQ: GOSS)</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/efx-ubs-raises-equifax-nyse-efx-price-target-to-215-reaffirms-buy</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-17T23:17:41Z</news:publication_date>
      <news:title>UBS Raises Equifax (NYSE: EFX) Price Target to $215, Reaffirms Buy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/abbv-abbvie-nyse-abbv-releases-phase-3-cll14-final-data-at-eha-2026-congress</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-17T23:14:42Z</news:publication_date>
      <news:title>AbbVie (NYSE: ABBV) Releases Phase 3 CLL14 Final Data at EHA 2026 Congress</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://alphastocksinsight.com/articles/swbi-smith-wesson-swbi-q4-adj-eps-0-36-beats-0-23-estimate-sales-hit-178-4m</loc>
    <news:news>
      <news:publication>
        <news:name>Alpha Stocks Insight</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-17T23:14:17Z</news:publication_date>
      <news:title>Smith &amp; Wesson (SWBI) Q4 Adj. EPS $0.36 Beats $0.23 Estimate; Sales Hit $178.4M</news:title>
    </news:news>
  </url>
</urlset>